Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2018The British Journal of PsychiatryOpen Access

Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKirsten C. MorleyThe University of SydneyABAndrew BaillieSydney Local Health DistrictIFI.S. FraserThe University of Sydney

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morley et al. (2018) studied this question.

synapsesocial.com/papers/6a5b684b1902b192aaf6945fhttps://doi.org/10.1192/bjp.2018.13
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Alcohol dependence syndrome: Measurement and validation.1982 · 968 citations
  2. 2A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients—The ALPADIR Study2017 · 144 citations
  3. 3Is Specialized Integrated Treatment for Comorbid Anxiety, Depression and Alcohol Dependence Better than Treatment as Usual in a Public Hospital Setting?2015 · 46 citations
  4. 4Randomized open-label trial of baclofen for relapse prevention in alcohol dependence2016 · 25 citations